Loading...

ACCELERATE DIAGNOSTICS INC Product Launches 8-K Filing

CCLR

ACCELERATE DIAGNOSTICS INC

()

2025 8-K

Asset Sale Agreement

Chapter 11 Bankruptcy

Chapter 11 Bankruptcy

Chapter 11 Bankruptcy

Compensatory Arrangements o...

Financial Results

Nasdaq Compliance Notice

Preliminary Results

Financial Results

Nasdaq Compliance

Note Purchase Agreement

Earnings Reports

Compliance regained with Na...

Dismissal of Previous Indep...

Compensation Committee Appr...

Private Placement Offering

Equity Incentive Plan Amend...

Financial Results Update

Earnings Reports

Public Offering and Private...

Financial Results Announcement

Agreement Extensions and Pr...

Collaboration Agreement

Earnings Reports

Earnings Reports

Compliance with Nasdaq List...

Agreements and Investments

Extension of Consent Condit...

Extension of Consent Condit...

Extension of Consent Condit...

Extension of Consent Condit...

Capital Structure Amendment

Extension of Consent Condit...

Extension of Consent Condit...

Extension of Consent Condit...

Extension of Consent Condit...

Earnings Reports

Debt Restructuring

Forbearance Agreement Exten...

Forbearance Agreement Exten...

Extension of Private Placement

Financial Results and Forbe...

Resignation and Appointment

Forbearance Agreement with ...

Retirement and Appointment ...

Restatement of Financial St...

Extension of Private Placement

External Links:

On March 21, 2025, Accelerate Diagnostics, Inc. announced it submitted its Accelerate WAVE system and a positive blood culture gram-negative test kit to the FDA for 510(k) clearance.

AI Assistant

ACCELERATE DIAGNOSTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.